Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013, Article ID 245804, 9 pages
http://dx.doi.org/10.1155/2013/245804
Research Article

IRF5 Is a Specific Marker of Inflammatory Macrophages In Vivo

1Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Drive, Headington, Oxford OX3 7FY, UK
2Leukocyte Biology Section, National Heart and Lung Institute, Sir Alexander Fleming Building, Faculty of Medicine, Imperial College, South Kensington, London SW7 2AZ, UK

Received 31 August 2013; Revised 29 November 2013; Accepted 30 November 2013

Academic Editor: Salahuddin Ahmed

Copyright © 2013 Miriam Weiss et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Mosser and J. P. Edwards, “Exploring the full spectrum of macrophage activation,” Nature Reviews Immunology, vol. 8, no. 12, pp. 958–969, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. S. K. Biswas and A. Mantovani, “Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm,” Nature Immunology, vol. 11, no. 10, pp. 889–896, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Gordon, “Alternative activation of macrophages,” Nature Reviews Immunology, vol. 3, no. 1, pp. 23–35, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. A. J. Fleetwood, T. Lawrence, J. A. Hamilton, and A. D. Cook, “Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation,” Journal of Immunology, vol. 178, no. 8, pp. 5245–5252, 2007. View at Google Scholar · View at Scopus
  5. F. A. W. Verreck, T. de Boer, D. M. L. Langenberg et al., “Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 13, pp. 4560–4565, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. J. A. Hamilton, “Colony-stimulating factors in inflammation and autoimmunity,” Nature Reviews Immunology, vol. 8, no. 7, pp. 533–544, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. F. A. W. Verreck, T. de Boer, D. M. L. Langenberg, L. van der Zanden, and T. H. M. Ottenhoff, “Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-γ- and CD40L-mediated costimulation,” Journal of Leukocyte Biology, vol. 79, no. 2, pp. 285–293, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Kennedy, U. Fearon, D. J. Veale, and C. Godson, “Macrophages in synovial inflammation,” Frontiers in Immunology, vol. 2, article 52, 2011. View at Publisher · View at Google Scholar
  9. T. J. M. Smeets, M. C. Kraan, S. Galjaard, P. P. Youssef, M. D. Smith, and P. P. Tak, “Analysis of the cell infiltrate and expression of matrix metalloproteinases and granzyme B in paired synovial biopsy specimens from the cartilage-pannus junction in patients with RA,” Annals of the Rheumatic Diseases, vol. 60, no. 6, pp. 561–565, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Barrera, “Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis,” Arthritis & Rheumatism, vol. 43, no. 9, pp. 1951–1959, 2000. View at Google Scholar
  11. P. L. E. M. van Lent, A. E. M. Holthuysen, N. van Rooijen, L. B. A. van de Putte, and W. B. van den Berg, “Local removal of phagocytic synovial lining cells by clodronate- liposomes decreases cartilage destruction during collagen type II arthritis,” Annals of the Rheumatic Diseases, vol. 57, no. 7, pp. 408–413, 1998. View at Google Scholar · View at Scopus
  12. K. Nistala, S. Adams, H. Cambrook et al., “Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 33, pp. 14751–14756, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Chabaud, E. Lubberts, L. Joosten, W. van den Berg, and P. Miossec, “IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis,” Arthritis Research, vol. 3, no. 3, pp. 168–177, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Krausgruber, K. Blazek, T. Smallie et al., “IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses,” Nature Immunology, vol. 12, no. 3, pp. 231–238, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Takaoka, H. Yanai, S. Kondo et al., “Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors,” Nature, vol. 434, no. 7030, pp. 243–249, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Honda and T. Taniguchi, “IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors,” Nature Reviews Immunology, vol. 6, no. 9, pp. 644–658, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. B. J. Barnes, P. A. Moore, and P. M. Pitha, “Virus-specific activation of a novel Interferon Regulatory Factor, IRF-5, results in the induction of distinct interferon α genes,” Journal of Biological Chemistry, vol. 276, no. 26, pp. 23382–23390, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. E. A. Stahl, S. Raychaudhuri, E. F. Remmers et al., “Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci,” Nature Genetics, vol. 42, no. 6, pp. 508–514, 2010. View at Google Scholar
  19. K. Dawidowicz, Y. Allanore, M. Guedj et al., “The Interferon Regulatory Factor 5 gene confers susceptibility to rheumatoid arthritis and influences its erosive phenotype,” Annals of the Rheumatic Diseases, vol. 70, no. 1, pp. 117–121, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. D. L. Asquith, A. M. Miller, I. B. McInnes, and F. Y. Liew, “Animal models of rheumatoid arthritis,” European Journal of Immunology, vol. 39, no. 8, pp. 2040–2044, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. P. J. Egan, A. van Nieuwenhuijze, I. K. Campbell, and I. P. Wicks, “Promotion of the local differentiation of murine Th17 cells by synovial macrophages during acute inflammatory arthritis,” Arthritis and Rheumatism, vol. 58, no. 12, pp. 3720–3729, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Y. Balkhi, K. A. Fitzgerald, and P. M. Pitha, “Functional regulation of MyD88-activated Interferon regulatory factor 5 by K63-linked polyubiquitination,” Molecular and Cellular Biology, vol. 28, no. 24, pp. 7296–7308, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. H. C. C. Foreman, S. van Scoy, T. F. Cheng, and N. C. Reich, “Activation of interferon regulatory factor 5 by site specific phosphorylation,” PLoS ONE, vol. 7, no. 3, Article ID e33098, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Y. Balkhi, K. A. Fitzgerald, and P. M. Pitha, “IKKα negatively regulates IRF-5 function in a MyD88-TRAF6 pathway,” Cellular Signalling, vol. 22, no. 1, pp. 117–127, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Inaba, M. Inaba, N. Romani et al., “Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor,” Journal of Experimental Medicine, vol. 176, no. 6, pp. 1693–1702, 1992. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Celada, M. J. Klemsz, and R. A. Maki, “Interferon-γ activates multiple pathways to regulate the expression of the genes for major histocompatibility class II I-Aβ, tumor necrosis factor and complement component C3 in mouse macrophages,” European Journal of Immunology, vol. 19, no. 6, pp. 1103–1109, 1989. View at Google Scholar · View at Scopus
  27. M. Rescigno, S. Citterio, C. Thèry et al., “Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 9, pp. 5229–5234, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. S. C. Sicher, G. W. Chung, M. A. Vazquez, and C. Y. Lu, “Augmentation or inhibition of IFN-γ-induced MHC class II expression by lipopolysaccharides: the roles of TNF-α and nitric oxide, and the importance of the sequence of signaling,” Journal of Immunology, vol. 155, no. 12, pp. 5826–5834, 1995. View at Google Scholar · View at Scopus
  29. R. de Lorenzi, R. Gareus, S. Fengler, and M. Pasparakis, “GFP-p65 knock-in mice as a tool to study NF-κB dynamics in vivo,” Genesis, vol. 47, no. 5, pp. 323–329, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. J. MacMicking, Q. W. Xie, and C. Nathan, “Nitric oxide and macrophage function,” Annual Review of Immunology, vol. 15, pp. 323–350, 1997. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Gordon and F. O. Martinez, “Alternative activation of macrophages: mechanism and functions,” Immunity, vol. 32, no. 5, pp. 593–604, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. E. L. Gautier, “Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages,” Nature Immunology, vol. 13, no. 11, pp. 1118–1128, 2012. View at Google Scholar
  33. R. C. Stone, D. Feng, J. Deng et al., “Interferon Regulatory Factor 5 activation in monocytes of systemic lupus erythematosus patients is triggered by circulating autoantigens independent of type i interferons,” Arthritis and Rheumatism, vol. 64, no. 3, pp. 788–798, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Draijer, P. Robbe, C. E. Boorsma, M. N. Hylkema, and B. N. Melgert, “Characterization of macrophage phenotypes in three murine models of house-dust-mite-induced asthma,” Mediators of Inflammation, vol. 2013, Article ID 632049, 10 pages, 2013. View at Publisher · View at Google Scholar
  35. V. Dideberg, G. Kristjansdottir, L. Milani et al., “An insertion-deletion polymorphism in the interferon regulatory factor 5 (IRF5) gene confers risk of inflammatory bowel diseases,” Human Molecular Genetics, vol. 16, no. 24, pp. 3008–3016, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Gathungu, C. K. Zhang, W. Zhang, and J. H. Cho, “A two-marker haplotype in the IRF5 gene is associated with inflammatory bowel disease in a North American cohort,” Genes and Immunity, vol. 13, no. 4, pp. 351–355, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Wang, M. J. Rose-Zerilli, G. H. Koppelman et al., “Evidence of association between Interferon Regulatory Factor 5 gene polymorphisms and asthma,” Gene, vol. 504, no. 2, pp. 220–225, 2012. View at Google Scholar
  38. W. D. Xu, H. F. Pan, Y. Xu, and D. Q. Ye, “Interferon regulatory factor 5 and autoimmune lupus,” Expert Reviews in Molecular Medicine, vol. 15, article e6, 2013. View at Google Scholar
  39. L. C. Davies, M. Rosas, S. J. Jenkins et al., “Distinct bone marrow-derived and tissue-resident macrophage lineages proliferate at key stages during inflammation,” Nature Communications, vol. 4, article 1886, 2013. View at Publisher · View at Google Scholar
  40. S. J. Jenkins, D. Ruckerl, P. C. Cook et al., “Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation,” Science, vol. 332, no. 6035, pp. 1284–1288, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. L. C. Davies, S. J. Jenkins, J. E. Allen, and P. R. Taylor, “Tissue-resident macrophages,” Nature Immunology, vol. 14, no. 10, pp. 986–995, 2013. View at Google Scholar